Why is Eiko Lifescience falling/rising?

As of 21-Aug, Eiko Lifesciences Ltd is experiencing a decline in its stock price, currently at 53.00, which reflects a decrease of 0.25 or 0.47%. The stock has been underperforming, having fallen consecutively for the last three days, resulting in a total decline of 2.93% during this period. Additionally, the stock's performance over the past week and month shows a decrease of 1.85% and 3.16%, respectively. While the stock is trading higher than its 100-day moving average, it remains below the 5-day, 20-day, 50-day, and 200-day moving averages. Notably, there has been a rise in investor participation, with delivery volume increasing by 58.84% compared to the 5-day average, indicating some interest despite the recent price drop.
In the broader market context, Eiko Lifesciences Ltd's performance contrasts sharply with the Sensex, which has gained 1.74% over the past week and is up 4.94% year-to-date. This indicates that while the stock is struggling, the overall market is performing well. The stock's year-to-date decline of 15.52% further emphasizes its underperformance compared to the benchmark's positive return. The lack of available positive or negative factors in the dashboard limits the analysis of specific influences on the stock's movement, but the overall trend suggests that Eiko Lifesciences is facing challenges in maintaining investor confidence amidst a rising market.